Target type: biologicalprocess
The chemical reactions and pathways resulting in the breakdown of phosphatidylglycerols, any of a class of glycerophospholipids in which the phosphatidyl group is esterified to the hydroxyl group of glycerol. [GOC:mah]
Phosphatidylglycerol (PG) catabolism is a critical pathway in cellular lipid metabolism, involving the breakdown of PG into its constituent components: glycerol, fatty acids, and phosphate. This process is essential for maintaining membrane integrity, regulating cellular signaling, and providing substrates for other metabolic pathways.
**Key enzymes and steps:**
1. **Phospholipase A2 (PLA2):** This enzyme hydrolyzes the ester bond at the sn-2 position of PG, releasing a free fatty acid and lysophosphatidylglycerol (LPG).
2. **Lysophospholipase A1 (LPLA1):** This enzyme cleaves the remaining fatty acid at the sn-1 position of LPG, generating glycerol-3-phosphate and a second free fatty acid.
3. **Glycerol-3-phosphate phosphatase:** This enzyme dephosphorylates glycerol-3-phosphate to produce glycerol.
**Regulation and significance:**
- **Cellular signaling:** PG catabolism can generate signaling molecules, such as lysophosphatidic acid (LPA), which is involved in various cellular processes, including cell growth, migration, and inflammation.
- **Membrane remodeling:** PG catabolism contributes to membrane remodeling by removing damaged or obsolete PG molecules, maintaining membrane fluidity and integrity.
- **Lipid metabolism:** The breakdown products of PG, such as glycerol and fatty acids, can be used as substrates for other metabolic pathways, such as gluconeogenesis (glycerol) and energy production (fatty acids).
- **Disease relevance:** Dysregulation of PG catabolism has been implicated in several diseases, including cancer, cardiovascular diseases, and inflammatory disorders.
**Overall, the phosphatidylglycerol catabolic process is a vital metabolic pathway that plays a crucial role in maintaining cellular homeostasis and regulating various physiological processes.**'
"
Protein | Definition | Taxonomy |
---|---|---|
Cytosolic phospholipase A2 | A cytosolic phospholipase A2 that is encoded in the genome of cow. [OMA:A4IFJ5, PRO:DNx] | Bos taurus (cattle) |
Cytosolic phospholipase A2 | A cytosolic phospholipase A2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P47712] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
ici 204,219 | zafirlukast: a leukotriene D4 receptor antagonist | carbamate ester; indoles; N-sulfonylcarboxamide | anti-asthmatic agent; leukotriene antagonist |
arachidonyltrifluoromethane | AACOCF3 : A fatty acid derivative that is arachidonic acid in which the OH part of the carboxy group has been replaced by a trifluoromethyl group arachidonyltrifluoromethane: structure given in first source; inhibits 85-kDa phospholipase A2 | fatty acid derivative; ketone; olefinic compound; organofluorine compound | EC 3.1.1.4 (phospholipase A2) inhibitor |
amentoflavone | biflavonoid; hydroxyflavone; ring assembly | angiogenesis inhibitor; antiviral agent; cathepsin B inhibitor; P450 inhibitor; plant metabolite | |
ochnaflavone | ochnaflavone : A biflavonoid with an ether linkage between the B-rings of the apigenin and luteolin subunits. It has been isolated from several members of the Ochnaceae plant family. ochnaflavone: from Lonicera japonica; structure given in first source | aromatic ether; biflavonoid; hydroxyflavone | anti-inflammatory agent; antiatherogenic agent; antibacterial agent; EC 3.1.1.4 (phospholipase A2) inhibitor; leukotriene antagonist; plant metabolite |
efipladib | efipladib: structure in first source | ||
methyl arachidonylfluorophosphonate | phosphonic ester | ||
pyrrophenone | pyrrophenone: structure in first source |